Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Meningococcal ACWY Disease”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Testing effectiveness (Phase 2)Study completedNCT00488683
What this trial is testing

B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants

Who this might be right for
Meningococcal Disease
Novartis Vaccines 216
Testing effectiveness (Phase 2)Study completedNCT00262002
What this trial is testing

Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Infants

Who this might be right for
Prevention of Meningococcal Disease
Novartis Vaccines 601
Post-approval studies (Phase 4)Study completedNCT00290329
What this trial is testing

Safety of Purified Meningococcal Vaccine With Serogroups ACWY, in 3,000 Filipino Subjects Aged > 2 Years

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 249
Large-scale testing (Phase 3)Study completedNCT01148017
What this trial is testing

Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine

Who this might be right for
Meningococcal Meningitis
Novartis Vaccines 433
Not applicableStudy completedNCT02287688
What this trial is testing

Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Infant Study

Who this might be right for
Meningococcal DiseaseInfections, Meningococcal
GlaxoSmithKline 144
Large-scale testing (Phase 3)Study completedNCT00518180
What this trial is testing

Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents

Who this might be right for
Meningococcal MeningitisHuman Papillomavirus InfectionPertussis+1 more
Novartis Vaccines 1,620
Large-scale testing (Phase 3)Study completedNCT01274897
What this trial is testing

A Multi-center, Observer-blind, Placebo-controlled, Randomized Study to Evaluate the Immunogenicity and Safety of MenACWY in Adolescents and Adults in Korea

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 450
Testing effectiveness (Phase 2)Study completedNCT00601731
What this trial is testing

Evaluation of Meningococcal ACWY Immune Response in Children Aged 40 and 60 Months

Who this might be right for
Meningococcal Disease
Novartis Vaccines 382
Large-scale testing (Phase 3)Study completedNCT03189745
What this trial is testing

Evaluate A Booster Dose Of Menacwy-tt Vaccine Administered 10 Years After Healthy Subjects Aged 11-17 Years Received Either Menacwy-tt Vaccine (Nimenrix(Registered)) Or Mencevax Acwy(Registered).

Who this might be right for
Meningococcal ACWY Disease
Pfizer 229
Testing effectiveness (Phase 2)Study completedNCT00427908
What this trial is testing

Study in Children to Evaluate Non-Inferiority and Persistence up to 5 Years of GSK Bio Meningococcal Vaccine 134612

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 613
Large-scale testing (Phase 3)Study completedNCT00450437
What this trial is testing

Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults

Who this might be right for
Meningococcal InfectionsMeningococcal Meningitis
Novartis Vaccines 3,539
Large-scale testing (Phase 3)Study completedNCT00474526
What this trial is testing

Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants

Who this might be right for
Meningitis, Meningococcal
Novartis Vaccines 4,545
Testing effectiveness (Phase 2)Study completedNCT03433482
What this trial is testing

Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age

Who this might be right for
Meningitis, Meningococcal
GlaxoSmithKline 1,707
Large-scale testing (Phase 3)Study completedNCT01725217
What this trial is testing

Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Children, Adolescents and Adults in Russia

Who this might be right for
Meningococcal Disease
Novartis Vaccines 198
Testing effectiveness (Phase 2)Study completedNCT01994629
What this trial is testing

Safety and Immunogenicity of One Dose of Novartis' Meningococcal ACWY-CRM Vaccine and GlaxoSmithKline Biologicals' Meningococcal ACWY-TT Vaccine in Healthy Toddlers

Who this might be right for
Meningococcal Disease
Novartis Vaccines 202
Large-scale testing (Phase 3)Study completedNCT00901940
What this trial is testing

Understanding the Immune Response to Meningitis Vaccines

Who this might be right for
MeningitisSepticemia
University of Oxford 150
Not applicableUnknownNCT04239430
What this trial is testing

Propositive (Protecting Positive People From Meningococcal Infection) Follow-up Study

Who this might be right for
HIV/AIDSMeningococcal Disease
St George's, University of London 55
Testing effectiveness (Phase 2)Study completedNCT00661557
What this trial is testing

Comparison of GSK134612 in Subjects Previously Vaccinated Against Meningococcal Disease Versus Non-vaccinated Subjects

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 271
Testing effectiveness (Phase 2)Study completedNCT00560313
What this trial is testing

Safety, Tolerability and Immunogenicity of Three Doses of Novartis Meningococcal B Vaccine When Administered to Healthy At-risk Adults

Who this might be right for
Meningococcal Disease
Novartis Vaccines 54
Large-scale testing (Phase 3)Study completedNCT00136604
What this trial is testing

Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m

Who this might be right for
Whole Cell PertussisHaemophilus Influenzae Type bHepatitis B+3 more
GlaxoSmithKline 617
Next Page